Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022;10(3):182-187.
doi: 10.1007/s40141-022-00352-9. Epub 2022 May 14.

Rehabilitation Strategies for Cognitive and Neuropsychiatric Manifestations of COVID-19

Affiliations
Review

Rehabilitation Strategies for Cognitive and Neuropsychiatric Manifestations of COVID-19

Summer Rolin et al. Curr Phys Med Rehabil Rep. 2022.

Abstract

Purpose of review: Extrapulmonary manifestations of COVID-19 are abundant, including after recovery of acute SARS-CoV-2 infection. This review seeks to explore the cognitive and neuropsychiatric manifestations of COVID-19 and post-acute sequelae of SARS-CoV-2 (PASC), including Long COVID syndromes. Furthermore, the review will discuss rehabilitation strategies for the emerging neurological consequences of COVID-19 to help those experiencing long-term effects of COVID-19.

Recent findings: There is emerging evidence depicting the neural involvement of COVID-19. Health priorities have shifted from understanding pathogenesis and treatment of pulmonary symptoms to targeting the acute and chronic sequelae of COVID-19, including cognitive and neuropsychiatric symptoms. The sequelae of COVID-19 often co-occur with other medical problems and is best managed by assessment and care across multiple disciplines. Symptoms following infection are similar to those found by other syndromes and disorders that disrupt the central nervous system.

Summary: The acute and chronic sequelae of COVID-19 have become major targets of current health care providers given its significant public health impact, inclusive of cognitive and neuropsychiatric sequelae. Assessment and referral to rehabilitation based on each individual's needs and symptoms can decrease morbidity and improve quality of life.

Keywords: Cognitive; Long COVID; Neuropsychiatric; Rehabilitation.

PubMed Disclaimer

Conflict of interest statement

Conflict of InterestDr. Rolin is a panelist and has received honorarium as an expert panelist for the Project ECHO Family Health Centers of San Diego (FHCSD) Long COVID and Fatiguing Illness Recovery Program (LC&FIRP). Dr. Verduzco-Gutierrez has received speaking honorarium for speaking on Long COVID. Ms. Chakales has no conflicts to disclose.

Similar articles

  • Chronic neuropsychiatric sequelae of SARS-CoV-2: Protocol and methods from the Alzheimer's Association Global Consortium.
    de Erausquin GA, Snyder H, Brugha TS, Seshadri S, Carrillo M, Sagar R, Huang Y, Newton C, Tartaglia C, Teunissen C, Håkanson K, Akinyemi R, Prasad K, D'Avossa G, Gonzalez-Aleman G, Hosseini A, Vavougios GD, Sachdev P, Bankart J, Mors NPO, Lipton R, Katz M, Fox PT, Katshu MZ, Iyengar MS, Weinstein G, Sohrabi HR, Jenkins R, Stein DJ, Hugon J, Mavreas V, Blangero J, Cruchaga C, Krishna M, Wadoo O, Becerra R, Zwir I, Longstreth WT, Kroenenberg G, Edison P, Mukaetova-Ladinska E, Staufenberg E, Figueredo-Aguiar M, Yécora A, Vaca F, Zamponi HP, Re VL, Majid A, Sundarakumar J, Gonzalez HM, Geerlings MI, Skoog I, Salmoiraghi A, Boneschi FM, Patel VN, Santos JM, Arroyo GR, Moreno AC, Felix P, Gallo C, Arai H, Yamada M, Iwatsubo T, Sharma M, Chakraborty N, Ferreccio C, Akena D, Brayne C, Maestre G, Blangero SW, Brusco LI, Siddarth P, Hughes TM, Zuñiga AR, Kambeitz J, Laza AR, Allen N, Panos S, Merrill D, Ibáñez A, Tsuang D, Valishvili N, Shrestha S, Wang S, Padma V, Anstey KJ, Ravindrdanath V, Blennow K, Mullins P, Łojek E, Pria A, Mosley TH, Gowland P, Girard TD, Bowtell R, Vahidy FS. de Erausquin GA, et al. Alzheimers Dement (N Y). 2022 Sep 22;8(1):e12348. doi: 10.1002/trc2.12348. eCollection 2022. Alzheimers Dement (N Y). 2022. PMID: 36185993 Free PMC article.
  • Effects of pulmonary rehabilitation on functional and psychological parameters in post-acute sequelae of SARS-CoV-2 infection (PASC) patients.
    Nasrullah A, Virk S, Javed A, Shah A, Ramanujam D, Sharma A, Gutierrez L, Nauer K, Maggio M, Yin Y, Bajwa Y, Cheema T, Disilvio B. Nasrullah A, et al. BMC Pulm Med. 2024 May 14;24(1):231. doi: 10.1186/s12890-024-03047-0. BMC Pulm Med. 2024. PMID: 38745298 Free PMC article.
  • The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
    Moghimi N, Di Napoli M, Biller J, Siegler JE, Shekhar R, McCullough LD, Harkins MS, Hong E, Alaouieh DA, Mansueto G, Divani AA. Moghimi N, et al. Curr Neurol Neurosci Rep. 2021 Jun 28;21(9):44. doi: 10.1007/s11910-021-01130-1. Curr Neurol Neurosci Rep. 2021. PMID: 34181102 Free PMC article. Review.
  • Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19.
    Stefano GB, Büttiker P, Weissenberger S, Ptacek R, Wang F, Esch T, Bilfinger TV, Raboch J, Kream RM. Stefano GB, et al. Curr Neuropharmacol. 2022;20(6):1229-1240. doi: 10.2174/1570159X20666211223130228. Curr Neuropharmacol. 2022. PMID: 34951387 Free PMC article.
  • Neuropsychiatric manifestations of COVID-19 and possible pathogenic mechanisms: Insights from other coronaviruses.
    Banerjee D, Viswanath B. Banerjee D, et al. Asian J Psychiatr. 2020 Dec;54:102350. doi: 10.1016/j.ajp.2020.102350. Epub 2020 Aug 12. Asian J Psychiatr. 2020. PMID: 33271682 Free PMC article. Review.

Cited by

References

    1. Higgins V, Sohaei D, Diamandis EP, Prassas I. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci. 2020;58(5):297–310. doi: 10.1080/10408363.2020.1860895. - DOI - PubMed
    1. Ritchie K, Chan D. The emergence of cognitive COVID. World Psychiatry. 2021;20(1):52–53. doi: 10.1002/wps.20837. - DOI - PMC - PubMed
    1. WHO coronavirus (COVID-19) dashboard. Covid19.who.int. https://covid19.who.int/. Published 2022. Accessed January 4, 2022.
    1. CDC COVID-19 Response Team Severe outcomes among patients with coronavirus disease 2019 (COVID-19) — United States, February 12–March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(12):343–346. doi: 10.15585/mmwr.mm6912e2. - DOI - PMC - PubMed
    1. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061. doi: 10.1001/jama.2020.1585. - DOI - PMC - PubMed

LinkOut - more resources